2 options
Wintrobe's clinical hematology / editors, John P. Greer, MD, Professor, Departments of Medicine and Pediatrics, Divisions of Hermatology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee ; Daniel A. Arber, MD, Professor and Vice Chair, Department of Pathology, Stanford University, Director of Anatomic and Clinical Pathology Services, Stanford University Medical Center, Stanford, California ; Bertil Glader, MD, Professor, Departments of Pediatrics and Pathology, Stanford University Medical Center, Stanford, California, Lucile Packard Children's Hospital, Palo Alto, California ; Alan F. List, MD, Senior Member, Department of Malignant Hematology, President and CEO, Moffit Cancer Center, Tampa Florida ; Robert T. Means Jr., MD, PhD, Professor of Internal Medicine, Executive Dean, University of Kentucky College of Medicine, Lexington, Kentucky ; Frixos Paraskevas, MD, Professor of Internal Medicine and Immunology (Retired), University of Mantioba Medical School, Associate Member, Institute of Cell Biology-Cancer Care, Mantioba, Winnipeg, Mantioba, Canada ; George M. Rodgers, MD, Professor of Medicine and Pathology, University of Utah School of Medicine, Health Sciences Center, Medical Director, Coagulation Laboratory, ARUB Laboratories, Salt Lake City, Utah ; Editor Emeritus, John Foerster, MD, FRCPC, Professor and Physician Emertius, Winnipeg, Canada.
- Format:
- Book
- Language:
- English
- Subjects (All):
- Blood.
- Hematologic Diseases.
- Hematology--methods.
- Hematology.
- Blood--Diseases.
- Medical Subjects:
- Blood.
- Hematologic Diseases.
- Hematology--methods.
- Physical Description:
- 1 online resource (xxvii, 2,278 pages) : illustrations (some color)
- Edition:
- Thirteenth edition.
- Other Title:
- Clinical hematology
- Place of Publication:
- Philadelphia : Wolters Kluwer, Lippincott Williams & Wilkins Health, [2014]
- Language Note:
- English
- Summary:
- "With the 13th edition of "Wintrobe's Clinical Hematology", Dr. Greer brings forth another text that bridges the gap between the clinical practice of hematology and the basic foundations of science. Revised to include a greater emphasis placed on biology and pathophysiology, this book offers the reader a clear understanding of the relationship between basic molecular biology and every aspect of the clinical practice of hematology. Coupled with this comprehensive overview, Dr. Greer presents a clear focus on clinical diagnosis and treatment of disease. Dr. Greer has added 7 entirely new chapters that are concisely reduced and dived in order to present more focused material. Additionally, the text provides a special section dedicated to transplantation, international editors, and over 1,400 full-color illustrations. This latest edition is an excellent resource for anyone studying Hemotology, Oncology, Internal Medicine, or Pathology. Features: 30% of the chapters have additional or new contributors, greater emphasis on molecular genetics and pathophysiology, increased number of hematopathology illustrations, diagrams, figures, standard and electron micrographs, algorithms, schemas, and protocols--all in color, 4-color halftones and 2-color computer generated illustrations spread throughout the book to reinforce understanding and application of method. The last three new chapters are entirely dedicated to Transplantation"--Provided by publisher.
- Contents:
- Wintrobe's Clinical Hematology, Thirteenth Edition
- Half Title Page
- Title Page
- Copyright
- Dedication
- CONTRIBUTORS
- PREFACE
- ACKNOWLEDGMENTS
- CONTENTS
- INTRODUCTION: THE DIAGNOSTIC AND THERAPEUTIC APPROACH TO HEMATOLOGIC PROBLEMS
- PART 1: Laboratory Hematology
- CHAPTER 1: EXAMINATION OF THE BLOOD AND BONE MARROW
- CHAPTER 2: CLINICAL FLOW CYTOMETRY
- CHAPTER 3: CYTOGENETICS
- CHAPTER 4: MOLECULAR DIAGNOSIS IN HEMATOLOGY
- PART II: The Normal Hematologic System
- CHAPTER 5: ORIGIN AND DEVELOPMENT OF BLOOD CELLS
- CHAPTER 6: THE BIRTH, LIFE, AND DEATH OF RED BLOOD CELLS: ERYTHROPOIESIS, THE MATURE RED BLOOD CELL, AND CELL DESTRUCTION
- CHAPTER 7: NEUTROPHILIC LEUKOCYTES
- CHAPTER 8: THE HUMAN EOSINOPHIL
- CHAPTER 9: MAST CELLS AND BASOPHILS: ONTOGENY, CHARACTERISTICS, AND FUNCTIONAL DIVERSITY
- CHAPTER 10: MONOCYTES, MACROPHAGES, AND DENDRITIC CELLS
- CHAPTER 11: LYMPHOCYTES AND LYMPHATIC ORGANS
- CHAPTER 12: B LYMPHOCYTES
- CHAPTER 13: T LYMPHOCYTES AND NATURAL KILLER CELLS
- CHAPTER 14: EFFECTOR MECHANISMS IN IMMUNITY
- CHAPTER 15: MEGAKARYOCYTES
- CHAPTER 16: PLATELET STRUCTURE AND FUNCTION IN HEMOSTASIS AND THROMBOSIS
- CHAPTER 17: PLATELET FUNCTION IN HEMOSTASIS AND THROMBOSIS
- CHAPTER 18: BLOOD COAGULATION AND FIBRINOLYSIS
- CHAPTER 19: ENDOTHELIUM: ANGIOGENESIS AND THE REGULATION OF HEMOSTASIS
- PART III: Transfusion Medicine
- CHAPTER 20: RED CELL, PLATELET, AND WHITE CELL ANTIGENS
- CHAPTER 21: TRANSFUSION MEDICINE
- PART IV: Disorders of Red Cells
- CHAPTER 22: ANEMIA: GENERAL CONSIDERATIONS
- CHAPTER 23: IRON DEFICIENCY AND RELATED DISORDERS
- CHAPTER 24: SIDEROBLASTIC ANEMIAS
- CHAPTER 25: HEMOCHROMATOSIS
- CHAPTER 26: PORPHYRIAS
- CHAPTER 27: HEREDITARY SPHEROCYTOSIS, HEREDITARY ELLIPTOCYTOSIS, AND OTHER DISORDERS ASOCIATED WITH ABNORMALITIES OF THE ERYTHROCYTE MEMBRANE.
- CHAPTER 28: HEREDITARY HEMOLYTIC ANEMIAS DUE TO RED BLOOD CELL ENZYME DISORDERS
- CHAPTER 29: AUTOIMMUNE HEMOLYTIC ANEMIA
- CHAPTER 30: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
- CHAPTER 31: PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
- CHAPTER 32: ACQUIRED NONIMMUNE HEMOLYTIC DISORDERS
- CHAPTER 33: SICKLE CELL ANEMIA AND OTHER SICKLING SYNDROMES
- CHAPTER 34: THALASSEMIAS AND RELATED DISORDERS: QUANTITATIVE DISORDERS OF HEMOGLOBIN SYNTHESIS
- CHAPTER 35: HEMOGLOBINS WITH ALTERED OXYGEN AFFINITY, UNSTABLE HEMOGLOBINS, M-HEMOGLOBINS, AND DYSHEMOGLOBINEMIAS
- CHAPTER 36: MEGALOBLASTIC ANEMIAS: DISORDERS OF IMPAIRED DNA SYNTHESIS
- CHAPTER 37: INHERITED APLASTIC ANEMIA SYNDROMES
- CHAPTER 38: ACQUIRED APLASTIC ANEMIA
- CHAPTER 39: RED CELL APLASIA: ACQUIRED AND CONGENITAL DISORDERS
- CHAPTER 40: CONGENITAL DYSERYTHROPOIETIC ANEMIAS
- CHAPTER 41: ANEMIAS SECONDARY TO CHRONIC DISEASE AND SYSTEMIC DISORDERS
- CHAPTER 42: ANEMIAS DURING PREGNANCY AND THE POSTPARTUM PERIOD
- CHAPTER 43: ANEMIAS UNIQUE TO THE FETUS AND NEONATE
- CHAPTER 44: ERYTHROCYTOSIS
- PART V: Disorders of Hemostasis and Coagulation
- CHAPTER 45: DIAGNOSTIC APPROACH TO THE BLEEDING DISORDERS
- CHAPTER 46: THROMBOCYTOPENIA: PATHOPHYSIOLOGY AND CLASSIFICATION
- CHAPTER 47: THROMBOCYTOPENIA CAUSED BY IMMUNOLOGIC PLATELET DESTRUCTION
- CHAPTER 48: THROMBOTIC THROMBOCYTOPENIC PURPURA, HEMOLYTIC-UREMIC SYNDROME, AND RELATED DISORDERS
- CHAPTER 49: MISCELLANEOUS CAUSES OF THROMBOCYTOPENIA
- CHAPTER 50: BLEEDING DISORDERS CAUSED BY VASCULAR ABNORMALITIES
- CHAPTER 51: THROMBOCYTOSIS AND ESSENTIAL THROMBOCYTHEMIA
- CHAPTER 52: QUALITATIVE DISORDERS OF PLATELET FUNCTION
- CHAPTER 53: INHERITED COAGULATION DISORDERS
- CHAPTER 54: ACQUIRED COAGULATION DISORDERS
- CHAPTER 55: THROMBOSIS AND ANTITHROMBOTIC THERAPY.
- PART VI: Benign Disorders of Leukocytes, the Spleen, and/or Immunoglobins
- CHAPTER 56: DIAGNOSTIC APPROACH TO MALIGNANT AND NONMALIGNANT DISORDERS OF THE PHAGOCYTIC AND IMMUNE SYSTEMS
- CHAPTER 57: NEUTROPENIA
- CHAPTER 58: QUALITATIVE DISORDERS OF LEUKOCYTES
- CHAPTER 59: LYSOSOMAL ABNORMALITIES OF THE MONOCYTE-MACROPHAGE SYSTEM: GAUCHER AND NIEMANN-PICK DISEASES
- CHAPTER 60: LANGERHANS CELL HISTIOCYTOSIS
- CHAPTER 61: PATHOLOGY OF LANGERHANS CELL HISTIOCYTOSIS AND OTHER HISTIOCYTIC PROLIFERATIONS
- CHAPTER 62: INFECTIOUS MONONUCLEOSIS AND OTHER EPSTEIN-BARR VIRUS-RELATED DISORDERS
- CHAPTER 63: PRIMARY IMMUNODEFICIENCY SYNDROMES
- CHAPTER 64: ACQUIRED IMMUNODEFICIENCY SYNDROME
- CHAPTER 65: DISORDERS OF THE SPLEEN
- CHAPTER 66: TUMORS OF THE SPLEEN
- PART VII: Hematologic Malignancies
- CHAPTER 67: HEMATOPOIETIC NEOPLASMS: PRINCIPLES OF PATHOLOGIC DIAGNOSIS
- CHAPTER 68: PRINCIPLES AND PHARMACOLOGY OF CHEMOTHERAPY
- CHAPTER 69: SUPPORTIVE CARE IN HEMATOLOGIC MALIGNANCIES
- CHAPTER 70: IMMUNOTHERAPY
- CHAPTER 71: GENE THERAPY FOR HEMATOLOGIC DISORDERS
- CHAPTER 72: MOLECULAR GENETICS OF ACUTE LEUKEMIA
- CHAPTER 73: DIAGNOSIS AND CLASSIFICATION OF THE ACUTE LEUKEMIAS AND MYELODYSPLASTIC SYNDROMES
- CHAPTER 74: ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS
- CHAPTER 75: ACUTE MYELOID LEUKEMIA IN ADULTS
- CHAPTER 76: ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN
- CHAPTER 77: ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN
- CHAPTER 78: ACUTE PROMYELOCYTIC LEUKEMIA
- CHAPTER 79: THE MYELODYSPLASTIC SYNDROMES
- CHAPTER 80: PATHOLOGY OF THE MYELOPROLIFERATIVE NEOPLASMS
- CHAPTER 81: CHRONIC MYELOID LEUKEMIA
- CHAPTER 82: POLYCYTHEMIA VERA
- CHAPTER 83: MYELOFIBROSIS
- CHAPTER 84: EOSINOPHILIC NEOPLASMS AND HYPEREOSINOPHILIC SYNDROME
- CHAPTER 85: SYSTEMIC MASTOCYTOSIS
- CHAPTER 86: DIAGNOSIS AND CLASSIFICATION OF LYMPHOMAS.
- CHAPTER 87: MOLECULAR GENETIC ASPECTS OF NON-HODGKIN LYMPHOMAS
- CHAPTER 88: NON-HODGKIN LYMPHOMA IN ADULTS
- CHAPTER 89: NON-HODGKIN LYMPHOMA IN CHILDREN
- CHAPTER 90: CHRONIC LYMPHOCYTIC LEUKEMIA
- CHAPTER 91: HAIRY CELL LEUKEMIA
- CHAPTER 92: CUTANEOUS T-CELL LYMPHOMA: MYCOSIS FUNGOIDES AND SÉZARY SYNDROME
- CHAPTER 93: HODGKIN LYMPHOMA IN ADULTS
- CHAPTER 94: HODGKIN LYMPHOMA IN CHILDREN
- CHAPTER 95: PRACTICAL APPROACH TO EVALUATION OF MONOCLONAL GAMMOPATHIES
- CHAPTER 96: MOLECULAR GENETIC ASPECTS OF PLASMA CELL DISORDERS
- CHAPTER 97: MONOCLONAL GAMMOPATHIES OF UNDETERMINED SIGNIFICANCE AND SMOLDERING MULTIPLE MYELOMA
- CHAPTER 98: MULTIPLE MYELOMA
- CHAPTER 99: IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS (PRIMARY AMYLOIDOSIS)
- CHAPTER 100: WALDENSTRÖM MACROGLOBULINEMIA
- CHAPTER 101: POEMS SYNDROME, CRYOGLOBULINEMIA, AND HEAVY-CHAIN DISEASE
- PART VIII: Transplantation
- CHAPTER 102: HEMATOPOIETIC CELL TRANSPLANTATION
- CHAPTER 103: HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NONMALIGNANT DISORDERS
- CHAPTER 104: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HCT) FOR HEMATOLOGIC MALIGNANCIES
- CHAPTER 105: GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-TUMOR RESPONSE
- CHAPTER 106: LATE EFFECTS AFTER TRANSPLANTATION
- Appendices
- APPENDIX A: CLUSTERS OF DIFFERENTIATION
- CELL MEMBRANE PROTEINS
- PROTEIN FAMILIES
- COMPLEMENT CONTROL PROTEIN DOMAIN
- CLUSTERS OF DIFFERENTIATION
- CD2 (T-11, LEU-5, SRBC RECEPTOR)
- CD3 (T3, LEU-4)
- CD4 (T4, LEU-3A, 3B)
- CD5 (LEU-1)
- CD6
- CD7
- CD8 (T-8, LEU-2)
- CD9
- CD10 (COMMON ACUTE LYMPHOCYTIC LEUKEMIA ANTIGEN, NEPRILYSIN).
- CD11A (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1α SUBUNIT)
- CD11B (α-M, CR-3, MAC 1)
- CD11C (INTEGRIN αX, P150)
- CD11D (α-D)
- CD13 (MY-7, AMINOPEPTIDASE N)
- CD14 (LIPOPOLYSACCHARIDE RECEPTOR)
- CD15 (LEWISX, CD15-S, SIALYL-LEWISX).
- CD16 (FCGR-III)
- CD18 (β-2 INTEGRIN)
- CD19 (B4)
- CD20 (B1)
- CD21 (CR2, EPSTEIN-BARR VIRUS RECEPTOR, C3D RECEPTOR)
- CD22 (B-5, LEU-14)
- CD23 (LEU-20, BLAST-2, FCεR-II)
- CD24
- CD25 (TAC ANTIGEN, α-CHAIN OF INTERLEUKIN-2 RECEPTOR)
- CD27
- CD28
- CD29 (β1 INTEGRIN CHAIN, VERY LATE ANTIGEN β-CHAIN, PLATELET GLYCOPROTEIN IIa)
- CD30 (KI-1, BERH2 ANTIGEN)
- CD31 (PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1)
- CD32 (FCGR2)
- CD33 (THE SIALIC ACID-BINDING IMMUNOGLOBULIN SUPERFAMILY LECTIN-3)
- CD34 (MY10, SGP90)
- CD35 (COMPLEMENT RECEPTOR 1: CR1, C3BR, C4BR)
- CD36 (PLATELET GLYCOPROTEIN IV)
- CD38 (ADENOSINE DIPHOSPHATE - RIBOSYLCYCLASE, CYCLIC ADENOSINE DIPHOSPHATE, RIBOSE HYDROLASE).
- CD39 (ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE-1, APYRASE, ECTOADENOSINE TRIPHOSPHATASE)
- CD40
- CD41 (INTEGRIN α-IIB SUBUNIT, PLATELET GLYCOPROTEIN IIB OF THE IIB/IIIA COMPLEX)
- CD42: CD42A (GPIX)
- CD42B (GPIBα)
- CD42C (GPIBβ)
- CD42D (GPV)
- CD43 (LEUKOSIALIN, SIALOPHORIN, WISKOTT-ALDRICH SYNDROME PROTEIN)
- CD44 (PHAGOCYTIC GLYCOPROTEIN -1)
- CD45 (LEUKOCYTE COMMON ANTIGEN, B220)
- CD46 (COMPLEMENT MEMBRANE COFACTOR PROTEIN)
- CD47 (INTEGRIN-ASSOCIATED PROTEIN, RH-ASSOCIATED PROTEIN, NEUROPHILIN)
- CD48 (BLAST)
- CD49: CD49A (VLA-1) TO CD49F (VLA-6)
- CD50 (ICAM3
- ICAM RECEPTOR)
- CD51 (α-SUBUNIT OF VITRONECTIN RECEPTOR, INTEGRIN αV-SUBUNIT)
- CD52 (CAMPATH-1)
- CD54 (INTERCELLULAR ADHESION MOLECULE 1)
- CD55 (COMPLEMENT DECAY-ACCELERATING FACTOR)
- CD56 (NEURAL CELL ADHESION MOLECULE)
- CD57 (HUMAN NATURAL KILLER CELL-1 ANTIGEN, LEU7 ANTIGEN)
- CD58 (LEUKOCYTE FUNCTION ANTIGEN-3)
- CD59 (COMPLEMENT PROTECTIN
- MEMBRANE INHIBITOR REACTIVE LYSIS
- HOMOLOGOUS RESTRICTION FACTOR 20)
- CD61 (INTEGRIN β3 SUBUNIT)
- CD62 (SELECTINS)
- CD63 (GRANULOPHYSIN)
- CD64 (FCGR1).
- CD66 (CARCINOEMBRYONIC ANTIGEN FAMILY).
- Notes:
- "Includes fulltext online with regular content updates."
- Includes bibliographical references and index.
- ISBN:
- 9781469838205
- 1469838206
- 9781469846231
- 1469846233
- 9781469846224
- 1469846225
- OCLC:
- 908512902
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.